Ponatinib in the treatment of patients with chronic myeloid leukemia and increased cardiovascular risk: A review of management strategies Tomasz Sacha; Katarzyna Krawczyk;

Epidemiological characterization of chronic myeloid leukaemia patients at an oncologic centre: A retrospective observational study Ana Maria Meireles; Rita Calisto; Maria José Bento; Pedro Martinho Gouveia; Susana Bizarro; Manuel Teixeira; Cláudia Moreira; Ana Espírito Santo; Mário Mariz;

Effect of blood groups on acquired and congenital thrombotic thrombocytopenic purpura and clinical correlation: Multi-center Turkish cohort study Cevat ¿lteri¿ K¿k¿l¿; Damla Ortaboz; Melek Yana¿¿k; Muhlis Cem Ar; Sevgi Kalayo¿lu Be¿¿¿¿k;